
Koltrap 0.125mg Tablet
Marketer
Pax Healthcare
Salt Composition
Methylergometrine (0.125mg)
Overview Koltrap 0.125mg Tablet
Uterine bleeding following childbirth or termination of pregnancy may be managed with Hemostop 0.125mg tablets. This medication acts on uterine smooth muscle, enhancing contractile strength, frequency, and intensity to minimize blood loss. Hemostop 0.125mg tablets can be ingested with or without food, but consistent timing maximizes efficacy. Dosage and frequency are determined by your physician based on individual needs and should be followed precisely. The prescribed duration of treatment should be completed. Swallow tablets whole with water. Common side effects include headache, elevated blood pressure, and convulsions. Report any concerning or severe side effects to your doctor; mitigation strategies may be available. Alcohol consumption is generally discouraged during treatment. Prior to commencing therapy, inform your physician of any pre-existing heart conditions or hypertension, and provide a complete list of all current medications, as interactions may reduce Hemostop's effectiveness or alter its action.
Uses of Koltrap 0.125mg Tablet
Hemorrhage postpartum
Major Benefits of Koltrap 0.125mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Koltrap 0.125mg Tablet whole; do not crush, chew, or divide it. This medication can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Koltrap 0.125mg Tablet:
- High blood pressure
- Headache
- Seizure
How to use Koltrap 0.125mg Tablet:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Koltrap 0.125mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Koltrap 0.125mg Tablet works:
Ergotamine-based Koltrap 0.125mg tablets induce prolonged uterine smooth muscle constriction. This vascular compression effectively manages postpartum hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Koltrap 0.125mg Tablets may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
Using Koltrap 0.125mg tablets during pregnancy is strongly contraindicated. Pregnant women should consult their physician; research in both animals and pregnant humans reveals substantial risks to fetal development.
Breast feedingCAUTION
Use of Koltrap 0.125mg tablets requires careful consideration while breastfeeding. Mothers should discontinue breastfeeding throughout their treatment and until the medication is fully cleared from their system.
DrivingCONSULT YOUR DOCTOR
Driving ability while taking Koltrap 0.125mg Tablets is undetermined. Refrain from driving should you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data on Koltrap 0.125mg Tablet use in individuals with impaired renal function is scarce. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Koltrap 0.125mg tablets to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Koltrap 0.125mg Tablet :
Should you forget a Koltrap 0.125mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Koltrap 0.125mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Ergoline alkaloids |
| Developing Good Habits | No. |
| Treatment Category | Obstetrics and Gynecology |
| Actions | Drugs inducing uterine contractions and abortion |
